公开(公告)号：US20080234468A1

公开(公告)日：2008-09-25

申请号：US11981466

申请日：2007-10-31

Applicant: Rachel E. Meyers ,  Joseph M. Carroll ,  William James Cook ,  Rosana Kapeller-Libermann ,  Nadine S. Weich ,  Rajasekhar Bandaru

Inventor： Rachel E. Meyers ,  Joseph M. Carroll ,  William James Cook ,  Rosana Kapeller-Libermann ,  Nadine S. Weich ,  Rajasekhar Bandaru

IPC: C07K14/00

CPC classification number: A61K38/16 ,  A01K2217/05 ,  A61K38/4813 ,  A61K39/00 ,  A61K2039/53 ,  C07K14/47 ,  C07K2319/00 ,  C12N9/0008 ,  C12N9/12 ,  C12N9/16 ,  C12N9/20 ,  C12N9/6416 ,  C12N9/6424 ,  C12N9/6491 ,  C12N9/93 ,  C12Q1/25 ,  C12Q1/37 ,  C12Q1/6883 ,  C12Q2600/156 ,  C12Q2600/158 ,  C12Y603/02019 ,  G01N33/5008 ,  G01N33/5011 ,  G01N33/502 ,  G01N33/573 ,  G01N33/68 ,  G01N2500/10 ,  Y10T436/143333 ,  A61K2300/00

Abstract: The invention provides isolated nucleic acids molecules, designated 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 gene has been introduced or disrupted. The invention still further provides isolated 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 proteins, fusion proteins, antigenic peptides and anti-27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供分离的核酸分子，命名为27877,18080,14081,32140,50352,16658,14223,16002,50566,65552和65577核酸分子。 本发明还提供反义核酸分子，含有27877,18080,14081,32140,50502,16658,14223,16002,50566,65552和65577核酸分子的重组表达载体，已经引入表达载体的宿主细胞，以及 已经引入或破坏了27877,18080,14081,32140,50352,16658,14223,16002,50566,65552或65577基因的非人类转基因动物。 本发明还进一步提供分离的27877,18080,14081,32140,50352,16658,14223,16002,50566,65552或65577蛋白，融合蛋白，抗原肽和抗27877,18080,14081,32140,50352,16658,14223 ，16002,50566,65552或65577抗体。 还提供了利用本发明组合物的诊断和治疗方法。

公开(公告)号：US07094587B2

公开(公告)日：2006-08-22

申请号：US10391364

申请日：2003-03-18

Applicant: Rachel E. Meyers ,  Joseph M. Carroll ,  William James Cook ,  Rosana Kapeller-Libermann ,  Nadine S. Weich ,  Rajasekhar Bandaru

Inventor： Rachel E. Meyers ,  Joseph M. Carroll ,  William James Cook ,  Rosana Kapeller-Libermann ,  Nadine S. Weich ,  Rajasekhar Bandaru

IPC: C12N9/12

CPC classification number: A61K38/16 ,  A01K2217/05 ,  A61K38/4813 ,  A61K39/00 ,  A61K2039/53 ,  C07K14/47 ,  C07K2319/00 ,  C12N9/0008 ,  C12N9/12 ,  C12N9/16 ,  C12N9/20 ,  C12N9/6416 ,  C12N9/6424 ,  C12N9/6491 ,  C12N9/93 ,  C12Q1/25 ,  C12Q1/37 ,  C12Q1/6883 ,  C12Q2600/156 ,  C12Q2600/158 ,  C12Y603/02019 ,  G01N33/5008 ,  G01N33/5011 ,  G01N33/502 ,  G01N33/573 ,  G01N33/68 ,  G01N2500/10 ,  Y10T436/143333 ,  A61K2300/00

Abstract: The invention provides isolated nucleic acids molecules, designated 16002 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 16002 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 16002 gene has been introduced or disrupted. The invention still further provides isolated 16002 proteins, fusion proteins, antigenic peptides and anti-16002 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供了分离的核酸分子，命名为16002核酸分子。 本发明还提供反义核酸分子，含有16002个核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及16002基因导入或破坏的非人转基因动物。 本发明还进一步提供了分离的16002蛋白，融合蛋白，抗原肽和抗-16002抗体。 还提供了利用本发明组合物的诊断和治疗方法。

公开(公告)号：US07045325B2

公开(公告)日：2006-05-16

申请号：US10664506

申请日：2003-09-17

Applicant: Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

Inventor： Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

IPC: C12N9/04 ,  C12N1/20 ,  C12N15/00 ,  C12P21/04 ,  C07H21/04

CPC classification number: C12N9/0004 ,  C07K2319/00 ,  C12N9/0006

Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

公开(公告)号：US06627423B2

公开(公告)日：2003-09-30

申请号：US09838561

申请日：2001-04-18

Applicant: Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

Inventor： Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

IPC: C12N904

CPC classification number: C12N9/0004 ,  C07K2319/00 ,  C12N9/0006

Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供编码新型DHDR相关脱氢酶分子的分离的核酸分子，命名为DHDR核酸分子。 本发明还提供了反义核酸分子，含有DHDR核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及DHDR基因导入或破坏的非人类转基因动物。 本发明还进一步提供了分离的DHDR蛋白，融合蛋白，抗原肽和抗DHDR抗体。 还提供了利用本发明组合物的诊断方法。

公开(公告)号：US20100092941A1

公开(公告)日：2010-04-15

申请号：US12316383

申请日：2008-12-10

Applicant: Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

Inventor： Rachel Meyers ,  William James Cook ,  Mark Williamson ,  Laura A. Rudolph-Owen ,  Ruth Gimeno

IPC: C12Q1/70 ,  C07H21/00 ,  C12N15/63 ,  C12N5/00 ,  C12N1/00 ,  C12P21/00 ,  C07K7/08 ,  C07K14/00 ,  C07K16/00 ,  G01N33/53 ,  G01N33/68 ,  C12Q1/02

CPC classification number: C12N9/0004 ,  C07K2319/00 ,  C12N9/0006

Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供编码新型DHDR相关脱氢酶分子的分离的核酸分子，命名为DHDR核酸分子。 本发明还提供了反义核酸分子，含有DHDR核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及DHDR基因导入或破坏的非人类转基因动物。 本发明还进一步提供了分离的DHDR蛋白，融合蛋白，抗原肽和抗DHDR抗体。 还提供了利用本发明组合物的诊断方法。

公开(公告)号：US07611879B2

公开(公告)日：2009-11-03

申请号：US11981466

申请日：2007-10-31

Applicant: Rachel E. Meyers ,  William James Cook

Inventor： Rachel E. Meyers ,  William James Cook

IPC: C12N9/04 ,  C07K1/00

CPC classification number: A61K38/16 ,  A01K2217/05 ,  A61K38/4813 ,  A61K39/00 ,  A61K2039/53 ,  C07K14/47 ,  C07K2319/00 ,  C12N9/0008 ,  C12N9/12 ,  C12N9/16 ,  C12N9/20 ,  C12N9/6416 ,  C12N9/6424 ,  C12N9/6491 ,  C12N9/93 ,  C12Q1/25 ,  C12Q1/37 ,  C12Q1/6883 ,  C12Q2600/156 ,  C12Q2600/158 ,  C12Y603/02019 ,  G01N33/5008 ,  G01N33/5011 ,  G01N33/502 ,  G01N33/573 ,  G01N33/68 ,  G01N2500/10 ,  Y10T436/143333 ,  A61K2300/00

Abstract: The invention provides isolated nucleic acids molecules, designated 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 gene has been introduced or disrupted. The invention still further provides isolated 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 proteins, fusion proteins, antigenic peptides and anti-27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 or 65577 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供分离的核酸分子，命名为27877,18080,14081,32140,50352,16658,14223,16002,50566,65552和65577核酸分子。 本发明还提供反义核酸分子，含有27877,18080,14081,32140,50502,16658,14223,16002,50566,65552和65577核酸分子的重组表达载体，已经引入表达载体的宿主细胞，以及 已经引入或破坏了27877,18080,14081,32140,50352,16658,14223,16002,50566,65552或65577基因的非人类转基因动物。 本发明还进一步提供分离的27877,18080,14081,32140,50352,16658,14223,16002,50566,65552或65577蛋白，融合蛋白，抗原肽和抗27877,18080,14081,32140,50352,16658,14223 ，16002,50566,65552或65577抗体。 还提供了利用本发明组合物的诊断和治疗方法。

公开(公告)号：US07494793B2

公开(公告)日：2009-02-24

申请号：US11335810

申请日：2006-01-19

Applicant: Rachel Meyers ,  William James Cook

Inventor： Rachel Meyers ,  William James Cook

IPC: C12N9/04 ,  C12N15/00 ,  C12Q1/00 ,  C12Q1/68 ,  C12P21/04 ,  C07H21/04

CPC classification number: C12N9/0004 ,  C07K2319/00 ,  C12N9/0006

Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供编码新型DHDR相关脱氢酶分子的分离的核酸分子，命名为DHDR核酸分子。 本发明还提供了反义核酸分子，含有DHDR核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及DHDR基因导入或破坏的非人类转基因动物。 本发明还进一步提供了分离的DHDR蛋白，融合蛋白，抗原肽和抗DHDR抗体。 还提供了利用本发明组合物的诊断方法。

公开(公告)号：US06511834B1

公开(公告)日：2003-01-28

申请号：US09634955

申请日：2000-08-08

Applicant: Rachel Meyers ,  William James Cook

Inventor： Rachel Meyers ,  William James Cook

IPC: C12N904

CPC classification number: C12N9/0004 ,  C07K2319/00

Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供编码新型DHDR相关脱氢酶分子的分离的核酸分子，命名为DHDR核酸分子。 本发明还提供了反义核酸分子，含有DHDR核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及DHDR基因导入或破坏的非人类转基因动物。 本发明还进一步提供了分离的DHDR蛋白，融合蛋白，抗原肽和抗DHDR抗体。 还提供了利用本发明组合物的诊断方法。

公开(公告)号：US06413757B1

公开(公告)日：2002-07-02

申请号：US09514521

申请日：2000-02-28

Applicant: William James Cook ,  Rory A. J. Curtis ,  Frank Spaltmann

Inventor： William James Cook ,  Rory A. J. Curtis ,  Frank Spaltmann

IPC: C12N914

CPC classification number: C12N9/78

Abstract: The present invention relates to a newly identified human agmatinase-like arginase, designated “25312”. The invention also relates to polynucleotides encoding the agmatinase-like arginase. The invention further relates to methods using the agmatinase-like polypeptides and polynucleotides as a target for diagnosis and treatment in disorders mediated by or related to the agmatinase-like arginase. The invention further relates to drug-screening methods using the polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the polypeptides and polynucleotides. The invention further relates to agonists and antagonists identified by drug screening methods with the polypeptides and polynucleotides as a target.

Abstract translation: 本发明涉及一种新鉴定的人类神经胶质蛋白酶样精氨酸酶，命名为“25312”。 本发明还涉及编码腺苷酸酶样精氨酸酶的多核苷酸。 本发明进一步涉及使用类肽酶多肽和多核苷酸作为用于诊断和治疗在由或者与其类似精氨酸酶精氨酸酶相关的病症中的靶标的方法。 本发明还涉及使用多肽和多核苷酸鉴定用于诊断和治疗的激动剂和拮抗剂的药物筛选方法。 本发明还包括基于多肽和多核苷酸的激动剂和拮抗剂。 本发明还涉及通过药物筛选方法鉴定的激动剂和拮抗剂，以多肽和多核苷酸为靶标。

公开(公告)号：US07098015B2

公开(公告)日：2006-08-29

申请号：US10386414

申请日：2003-03-11

Applicant: Kyle J. MacBeth ,  Joseph M. Carroll ,  William James Cook ,  Rachel E. Meyers ,  Miyoung Chun ,  Mark J. Williamson

Inventor： Kyle J. MacBeth ,  Joseph M. Carroll ,  William James Cook ,  Rachel E. Meyers ,  Miyoung Chun ,  Mark J. Williamson

IPC: C12N9/16 ,  C12N15/54 ,  C12N15/62 ,  C12N15/79

CPC classification number: G01N33/5008 ,  A61K38/00 ,  C12N9/1007 ,  C12N9/16 ,  C12N9/6489 ,  C12Q1/37 ,  C12Q1/6883 ,  C12Q2600/158 ,  C12Y301/04017 ,  G01N33/5011 ,  G01N33/502 ,  G01N33/56983 ,  G01N33/56994 ,  G01N33/57426 ,  G01N33/5761 ,  G01N33/5767 ,  G01N33/68 ,  G01N2333/916 ,  G01N2333/96486 ,  G01N2500/04

Abstract: The invention provides isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27875, 22025, 27420, 16319, 55092 and 10218 gene has been introduced or disrupted. The invention still further provides isolated 27875, 22025, 27420, 17906, 16319, 55092 or 10218 proteins, fusion proteins, antigenic peptides and anti-27875, 22025, 27420, 17906, 16319, 55092 or 10218 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Abstract translation: 本发明提供分离的核酸分子，命名为27875,22025,27420,16319,55092和10218核酸分子。 本发明还提供反义核酸分子，含有27875,22025,27420,16319,55092和10218核酸分子的重组表达载体，已经引入表达载体的宿主细胞，以及非人类转基因动物，其中27875,22025， 27420,16319,55092和10218基因已被引入或破坏。 本发明还进一步提供了分离的27875,22025,27420,17906,16319,55092或10218蛋白，融合蛋白，抗原肽和抗27875,22025,27420,17906,16319,55092或10218抗体。 还提供了利用本发明组合物的诊断和治疗方法。